(4-(5-fluoro-6-(2-methyl-6-(methylsulfonyl)pyridin-3-yloxy)pyrimidin-4-yloxy)piperidin-1-yl)(1-fluorocyclobutyl)methanone

ID: ALA3326682

Chembl Id: CHEMBL3326682

PubChem CID: 118711791

Max Phase: Preclinical

Molecular Formula: C21H24F2N4O5S

Molecular Weight: 482.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(S(C)(=O)=O)ccc1Oc1ncnc(OC2CCN(C(=O)C3(F)CCC3)CC2)c1F

Standard InChI:  InChI=1S/C21H24F2N4O5S/c1-13-15(4-5-16(26-13)33(2,29)30)32-19-17(22)18(24-12-25-19)31-14-6-10-27(11-7-14)20(28)21(23)8-3-9-21/h4-5,12,14H,3,6-11H2,1-2H3

Standard InChI Key:  USJBZXQTBYDIJL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3326682

    ---

Associated Targets(Human)

GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr119 Glucose-dependent insulinotropic receptor (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 482.51Molecular Weight (Monoisotopic): 482.1435AlogP: 2.78#Rotatable Bonds: 6
Polar Surface Area: 111.58Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 0.67CX LogP: 1.54CX LogD: 1.54
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.62Np Likeness Score: -0.93

References

1. Buzard DJ, Kim SH, Lehmann J, Han S, Calderon I, Wong A, Kawasaki A, Narayanan S, Bhat R, Gharbaoui T, Lopez L, Yue D, Whelan K, Al-Shamma H, Unett DJ, Shu HH, Tung SF, Chang S, Chuang CF, Morgan M, Sadeque A, Chu ZL, Leonard JN, Jones RM..  (2014)  Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists.,  24  (17): [PMID:25088191] [10.1016/j.bmcl.2014.06.071]

Source